UTRGV researchers will receive $123,000 for a three-year project funded by the Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia
The UTRGV School of Medicine has received funding to study genetic polymorphism in Ovarian Cancer patients from the Research and Development Office, Ministry of Education, in Saudi Arabia.
The International Collaboration Grant with King Abdulaziz University in Saudi Arabia collaboration agreement has been recently finalized. UTRGV School of Medicine researchers will receive $123,000 for a three-year project funded by the Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia, under grant number (1171).
The active grant will be funded by the KSA International Collaboration and the Research and Development Office, Ministry of Education of Saudi Arabia.
The study's title will be "Genetic Polymorphism of IL-6, IL-8 and CRP genes as Prognostic Biomarkers for Chemotherapeutic Response in Saudi and American Ovarian Cancer patients".
The proposal is unique and has been developed after strikingly observing differential transcripts and SNPs in IL-6, IL-8, and CRP genes. The information on the genetic polymorphism of these critical genes will help establish authentic predictive biomarkers for a chemotherapeutic response for Saudi and American ovarian cancer patients. This proposal has the potential for developing a better and early prognostic marker for chemotherapeutic response in ovarian cancer for a better outcome.
The PIs from the UTRGV School of Medicine include Manish K. Tripathi, assistant professor for the Department of Immunology and Microbiology; Bilal B. Hafeez, assistant professor for the Department of Immunology and Microbiology; and Absarul Haque, principal grant investigator and associate professor for the King Fahd Medical Research Centre at the King Abdulaziz University in Jeddah, Saudi Arabia.